Tragedy Unfolds: Japan's Probe into Supplement-Linked Deaths
According to the latest announcement from Japan's Ministry of Health, Labor and Welfare, as of July 11th, a serious incident involving a health supplement containing red yeast from the Kobayashi Pharmaceutical Company has drawn widespread attention. The report states that the suspected death toll from consuming this supplement has now risen to 100 cases, undoubtedly sounding the alarm for public health.
Since the incident was first made public, 249 families of deceased consumers have proactively contacted Kobayashi Pharmaceutical to seek the truth. Among these, 146 cases lack detailed medical records or sufficient information from the families, making it impossible to confirm if the deceased had indeed consumed the problematic supplement. Additionally, 3 other cases are currently under intense investigation to determine if the supplement was the direct cause of death.
The complexity of this issue lies in the fact that red yeast is generally considered a natural food additive with benefits such as regulating blood lipids. However, when consumed in the form of a health supplement, potentially in excessive doses or with interactions with other medications, unexpected side effects may arise. Thus, the Ministry of Health, Labor and Welfare is closely collaborating with local health departments, forensic institutions, and Kobayashi Pharmaceutical to conduct in-depth pathological and epidemiological investigations on the remaining 100 death cases, in order to establish the causal relationship with the problematic supplement.
Concurrently, the Japanese government is urging the public to exercise caution when using health supplements containing red yeast while awaiting the investigation results, and advising consumers currently taking similar products to immediately consult with a doctor. Furthermore, the Ministry is considering strengthening the regulation of the health supplement market to prevent the recurrence of such incidents.
This event not only poses a grave challenge for Japan, but also the global health supplement industry as a whole. It reminds us that even in the pursuit of a healthy lifestyle, we cannot overlook any potential risks, and the use of any health supplement should be under the guidance of a medical professional. As the investigation deepens, we look forward to a fair and scientific conclusion that will protect consumer rights and public health.
2026-08-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Congo Copper and Cobalt Miners Are Being Forced to Cut Chemical Use as Middle East Conflict Hits the New Energy Supply Chain
-
China’s PPI Finally Hits the Brakes — But the Pain Isn’t Over
-
BP Kicks Off $25 Billion Redevelopment of Iraq’s Kirkuk Oilfields
-
Refining at a Crossroads: Asia and the Middle East Expand While the West Retreats
-
Europe’s Chemicals Industry Stalls Again as Cefic Cuts 2025 Outlook
-
LG Chem and GS Caltex in Talks to Merge Yeosu Cracker Assets as Korea Pushes Industry Restructuring
-
The Great Hydrogen Reality Check: Global Clean Hydrogen Projects Face Mass Cancellations
-
Europe’s Recycling Industry in Crisis: Cheap Imports and Red Tape Push Plastic Recyclers to the Brink
-
ConocoPhillips to Cut Up to 25% of Workforce as Oil Price Slump Bites
-
Evonik Starts Up 100,000 t/y Alkoxylates Plant in Singapore to Meet Surging Asian Demand
Recommend Reading
-
South Korea Approves Yeosu Restructuring Plan, Permanently Retiring 1.39 Million Tons of Ethylene Capacity
-
Lianolong Bets Big on Electronic Adhesives with $50M Strategic Stake in Sidofu
-
Antidumping Pressure Hits the Chemical Chain as Chinese Exports Face Higher Barriers in Europe
-
Sichuan Unveils Revised List of 14 Qualified Chemical Parks in Major Industrial Realignment
-
EU Puts Chemicals on Its China De-Risking Watchlist
-
Natural Rubber Market Trends Have Been Volatile and Consolidating Since July
-
Coke Market Prices Remain Stable with a Rising Trend
-
Strong Cost Support Drives Continued Strength in PTA Prices
-
Crude Oil Prices First Fall, Then Rise; Retail Prices for Refined Oil Products Raised Again in This Round
-
Insufficient Demand for Cyclohexane in China, Prices Narrowly Fluctuate